tiprankstipranks
Advertisement
Advertisement

HK:3692 Stock Latest News

Why Is Penny Stock NextCure (NXTC) Up Today?
Market NewsWhy Is Penny Stock NextCure (NXTC) Up Today?
9d ago
NXTC
Hansoh Pharma Licenses IL-23 Drug to Avere and Gains Major Stake in Nasdaq-Bound Merger
PremiumCompany Announcements
Hansoh Pharma Licenses IL-23 Drug to Avere and Gains Major Stake in Nasdaq-Bound Merger
9d ago
3692
Hansoh Pharma’s HS-20093 Meets Phase III Survival Goal in Small Cell Lung Cancer
PremiumCompany Announcements
Hansoh Pharma’s HS-20093 Meets Phase III Survival Goal in Small Cell Lung Cancer
13d ago
3692
Hansoh Pharma Wins NMPA Trial Approvals for New Metabolic Injection
PremiumCompany Announcements
Hansoh Pharma Wins NMPA Trial Approvals for New Metabolic Injection
21d ago
3692
Hansoh Pharmaceutical Shareholders Approve All Resolutions at 2026 AGM
PremiumCompany Announcements
Hansoh Pharmaceutical Shareholders Approve All Resolutions at 2026 AGM
27d ago
3692
Hansoh Pharma Wins NMPA Nod to Review New Injection for Kidney-Disease Complication
PremiumCompany AnnouncementsHansoh Pharma Wins NMPA Nod to Review New Injection for Kidney-Disease Complication
1M ago
3692
Hansoh Pharmaceutical Reshapes Governance Team With New Joint Company Secretary
Premium
Company Announcements
Hansoh Pharmaceutical Reshapes Governance Team With New Joint Company Secretary
1M ago
3692
Hansoh Pharma Sets 2026 AGM to Approve 2025 Results, Dividend and Share Mandates
Premium
Company Announcements
Hansoh Pharma Sets 2026 AGM to Approve 2025 Results, Dividend and Share Mandates
2M ago
3692
Hansoh Pharma’s Weight-Loss Drug Olatorepatide Wins NDA Acceptance in China
PremiumCompany Announcements
Hansoh Pharma’s Weight-Loss Drug Olatorepatide Wins NDA Acceptance in China
2M ago
3692
Hansoh Pharma Wins NMPA Breakthrough Status for Fourth-Gen Lung Cancer Drug
PremiumCompany Announcements
Hansoh Pharma Wins NMPA Breakthrough Status for Fourth-Gen Lung Cancer Drug
2M ago
3692
Hansoh Pharmaceutical Reshuffles Company Secretary and Compliance Roles
PremiumCompany Announcements
Hansoh Pharmaceutical Reshuffles Company Secretary and Compliance Roles
2M ago
3692
Hansoh Pharma Wins NMPA Nod for Trial of New KRAS-Targeting Cancer Drug
PremiumCompany Announcements
Hansoh Pharma Wins NMPA Nod for Trial of New KRAS-Targeting Cancer Drug
2M ago
3692
Hansoh Pharmaceutical Wins Breakthrough Therapy Status for Esophageal Cancer ADC
PremiumCompany AnnouncementsHansoh Pharmaceutical Wins Breakthrough Therapy Status for Esophageal Cancer ADC
2M ago
3692
Hansoh Pharmaceutical Expands RSU Share Pool With Market Purchases
Premium
Company Announcements
Hansoh Pharmaceutical Expands RSU Share Pool With Market Purchases
3M ago
3692
Hansoh Hands KiOmed Osteoarthritis Licence to Hengrui in Strategic Refocus
Premium
Company Announcements
Hansoh Hands KiOmed Osteoarthritis Licence to Hengrui in Strategic Refocus
3M ago
3692
Hansoh Pharma Wins China Nod for Trials of New Hypertension Drug HS-10522
PremiumCompany Announcements
Hansoh Pharma Wins China Nod for Trials of New Hypertension Drug HS-10522
3M ago
3692
Hansoh Pharma Wins Breakthrough Therapy Designation in China for Prostate Cancer ADC
PremiumCompany Announcements
Hansoh Pharma Wins Breakthrough Therapy Designation in China for Prostate Cancer ADC
3M ago
3692
Hansoh Pharmaceutical Sets Final 2025 Dividend at HKD 0.20 Per Share
PremiumCompany Announcements
Hansoh Pharmaceutical Sets Final 2025 Dividend at HKD 0.20 Per Share
3M ago
3692
Hansoh Pharma Grants 5 Million RSUs to Staff Under Post-IPO Incentive Scheme
PremiumCompany Announcements
Hansoh Pharma Grants 5 Million RSUs to Staff Under Post-IPO Incentive Scheme
3M ago
3692
Hansoh Pharma Overhauls Equity Incentives With New 2026 Share Scheme
PremiumCompany AnnouncementsHansoh Pharma Overhauls Equity Incentives With New 2026 Share Scheme
3M ago
3692
Hansoh Pharma Wins China Breakthrough Therapy Status for Lung Cancer ADC Combo
Premium
Company Announcements
Hansoh Pharma Wins China Breakthrough Therapy Status for Lung Cancer ADC Combo
3M ago
3692
Hansoh Pharma Delivers Double-Digit 2025 Growth as Innovative Drugs Drive Earnings and Pipeline Wins
Premium
Company Announcements
Hansoh Pharma Delivers Double-Digit 2025 Growth as Innovative Drugs Drive Earnings and Pipeline Wins
4M ago
3692

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >